VIENNA — AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. Read More
Source link
Marjorie Taylor Greene knocks Trump for not focusing on domestic issues
In a high-profile interview, Rep. Marjorie Taylor Greene, R-Ga., bashed President Donald Trump, accusing her onetime political ally-turned-foe of inciting death threats against her and her son and failing to…







